id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2023-0029-41937,DEA,DEA-2023-0029,Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2025-12-31T05:00:00Z,2025,12,2025-12-31T05:00:00Z,,2026-01-13T03:01:01Z,2025-24123,0,0,09000064b9113f32
DEA-2023-0147-0004,DEA,DEA-2023-0147,Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I,Rule,,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,,2026-01-06T01:10:17Z,2025-23717,0,0,09000064b91067de
DEA-2025-0952-0001,DEA,DEA-2025-0952,2025-23469,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-01-21T04:59:59Z,2025-12-19T19:32:12Z,2025-23469,0,0,09000064b90f4ec6
DEA-2025-0953-0001,DEA,DEA-2025-0953,2025-23467,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-02-18T04:59:59Z,2026-01-09T02:23:39Z,2025-23467,0,0,09000064b90f4eeb
DEA-2025-0951-0001,DEA,DEA-2025-0951,2025-23466,Notice,,2025-12-19T05:00:00Z,2025,12,,,2026-01-09T02:25:15Z,,0,1,09000064b90f4e72
DEA-2025-0954-0001,DEA,DEA-2025-0954,2025-23468,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-01-21T04:59:59Z,2025-12-19T19:57:02Z,2025-23468,0,0,09000064b90f4f00
DEA-2025-0918-0003,DEA,DEA-2025-0918,251203 OASH to DEA draft letter 4 synthetic cannabinoids 8FA_signed 12032025,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:36Z,,0,0,09000064b90eed87
DEA-2025-0918-0005,DEA,DEA-2025-0918,4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor Analysis December 2025 DEA,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:42Z,,0,0,09000064b90eed89
DEA-2025-0918-0004,DEA,DEA-2025-0918,4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor December 2025 HHS,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:39Z,,0,0,09000064b90eed88
DEA-2025-0918-0002,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I",Proposed Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-23T10:00:13Z,2025-22963,0,0,09000064b90da711
DEA-2025-0918-0001,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act",Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T21:28:16Z,2025-22960,0,0,09000064b90da7df
DEA-2025-0885-0003,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 07102025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:51Z,,0,0,09000064b90d40f8
DEA-2025-0885-0002,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 06282024,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:46Z,,0,0,09000064b90d40f6
DEA-2025-0885-0001,DEA,DEA-2025-0885,Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I,Proposed Rule,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T20:45:21Z,2025-22763,0,0,09000064b90d3470
DEA-2025-0885-0004,DEA,DEA-2025-0885,DEA 3-Factor Analysis Bromazolam December 2025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:54Z,,0,0,09000064b90d40f7
DEA-2025-0852-0005,DEA,DEA-2025-0852,HHS Letter to DEA cumyl-PEGACLONE_112024,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:46:04Z,,0,0,09000064b90cb028
DEA-2025-0852-0007,DEA,DEA-2025-0852,HHS Letter to DEA cumyl-PEGACLONE_112024,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:33Z,,0,0,09000064b90cb02a
DEA-2025-0852-0006,DEA,DEA-2025-0852,CUMYL-PEGACLONE HHS 8 Factor Review,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:28Z,,0,0,09000064b90cb029
DEA-2025-0852-0008,DEA,DEA-2025-0852,CUMYL PEGACLONE DEA 8-Factor Analysis_1222025,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:36Z,,0,0,09000064b90cb02b
DEA-2025-0852-0004,DEA,DEA-2025-0852,CUMYL-PEGACLONE HHS 8 Factor Review,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:46:02Z,,0,0,09000064b90cb027
DEA-2025-0852-0003,DEA,DEA-2025-0852,CUMYL PEGACLONE DEA 8-Factor Analysis_1222025,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:45:59Z,,0,0,09000064b90cb026
DEA-2025-0555-0055,DEA,DEA-2025-0555,Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:41:46Z,2025-22540,0,0,09000064b90c55b5
DEA-2025-0852-0002,DEA,DEA-2025-0852,Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:46:09Z,2025-22496,0,0,09000064b90c55b7
DEA-2025-0852-0001,DEA,DEA-2025-0852,Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I,Proposed Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-01-13T04:59:59Z,2025-12-24T10:00:21Z,2025-22495,0,0,09000064b90c30e5
DEA-2025-0820-0001,DEA,DEA-2025-0820,2025-21790,Notice,,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,2025-02-04T04:59:59Z,2025-12-03T19:44:43Z,2025-21790,0,0,09000064b90ab305
DEA-2025-0687-0001,DEA,DEA-2025-0687,2025-21192 (1),Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,,2025-12-01T18:33:33Z,,0,0,09000064b90a17a3
DEA-2025-0762-0001,DEA,DEA-2025-0762,2025-21180,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T23:13:28Z,2025-21180,0,0,09000064b90a54c2
DEA-2025-0770-0001,DEA,DEA-2025-0770,2025-21190,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:40:21Z,2025-21190,0,0,09000064b90a7f1d
DEA-2025-0774-0001,DEA,DEA-2025-0774,2025-21724,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T01:23:44Z,2025-21724,0,0,09000064b90a8065
DEA-2025-0772-0001,DEA,DEA-2025-0772,2025-21187,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T01:09:04Z,2025-21187,0,0,09000064b90a7fa4
DEA-2025-0763-0001,DEA,DEA-2025-0763,2025-21181,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-05T10:00:17Z,2025-21181,0,0,09000064b90a54dc
DEA-2025-0757-0001,DEA,DEA-2025-0757,2025-21175,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:24:06Z,2025-21175,0,0,09000064b90a6a09
DEA-2025-0761-0001,DEA,DEA-2025-0761,2025-21179,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T22:02:52Z,2025-21179,0,0,09000064b90a67c5
DEA-2025-0769-0001,DEA,DEA-2025-0769,2025-21189,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-02T00:34:28Z,2025-21189,0,0,09000064b90a7f00
DEA-2025-0768-0001,DEA,DEA-2025-0768,2025-21186,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:15:42Z,2025-21186,0,0,09000064b90a67c7
DEA-2025-0764-0001,DEA,DEA-2025-0764,2025-21182,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T23:36:37Z,2025-21182,0,0,09000064b90a54df
DEA-2025-0773-0001,DEA,DEA-2025-0773,2025-21724,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T01:15:20Z,2025-21724,0,0,09000064b90a7fc6
DEA-2025-0765-0001,DEA,DEA-2025-0765,2025-21183,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T23:43:27Z,2025-21183,0,0,09000064b90a814e
DEA-2025-0753-0001,DEA,DEA-2025-0753,2025-21173,Notice,,2025-12-01T05:00:00Z,2025,12,2025-11-26T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T20:28:41Z,2025-21173,0,0,09000064b90a6905
DEA-2025-0760-0001,DEA,DEA-2025-0760,2025-21178,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:55:42Z,2025-21178,0,0,09000064b90a67c1
DEA-2025-0767-0001,DEA,DEA-2025-0767,2025-21185,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:03:58Z,2025-21185,0,0,09000064b90a7016
DEA-2025-0759-0001,DEA,DEA-2025-0759,2025-21176,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:42:35Z,2025-21176,0,0,09000064b90a6788
DEA-2025-0720-0001,DEA,DEA-2025-0720,2025-21191,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T20:12:52Z,DEA-2025-0720,0,0,09000064b90a5893
DEA-2025-0756-0001,DEA,DEA-2025-0756,2025-21174,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T21:10:37Z,2025-21174,0,0,09000064b90a69de
DEA-2025-0755-0001,DEA,DEA-2025-0755,2025-21174,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T20:45:50Z,2025-21174,0,0,09000064b90a6996
DEA-2025-0758-0001,DEA,DEA-2025-0758,2025-21176,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:33:01Z,DEA 2025-21176,0,0,09000064b90a6784
DEA-2025-0771-0001,DEA,DEA-2025-0771,2025-21720,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T00:50:08Z,2025-21720,0,0,09000064b90a7f54
DEA-2025-0766-0001,DEA,DEA-2025-0766,2025-21184,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T23:53:42Z,2025-21184,0,0,09000064b90a81ba
DEA-2025-0654-0001,DEA,DEA-2025-0654,Analysis for Proposed 2026 Aggregate Production Quotas and Assessment of Annual Needs,Notice,,2025-11-28T05:00:00Z,2025,11,2025-11-28T05:00:00Z,2025-12-16T04:59:59Z,2025-12-16T10:00:28Z,2025-21509,0,0,09000064b90a1b96
DEA-2024-0144-0006,DEA,DEA-2024-0144,Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I,Rule,,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-20T02:13:12Z,2025-20004,0,0,09000064b9085a3d
DEA-2025-0522-0002,DEA,DEA-2025-0522,2025-19317,Notice,,2025-10-31T04:00:00Z,2025,10,2025-10-31T04:00:00Z,2025-12-02T04:59:59Z,2025-10-31T14:38:02Z,2025-19317,0,0,09000064b905b0a2
DEA-2025-0588-0002,DEA,DEA-2025-0588,Seven benzimidazole opioids 811h no objection ASH to DEA 22Apr2025.AA,Supporting & Related Material,,2025-10-16T04:00:00Z,2025,10,,,2025-10-17T03:33:17Z,,0,0,09000064b902eca3
DEA-2025-0588-0001,DEA,DEA-2025-0588,"Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I",Rule,,2025-10-15T04:00:00Z,2025,10,2025-10-15T04:00:00Z,,2025-10-17T03:23:35Z,2025-19542,0,0,09000064b901aa49
DEA-2025-0555-0003,DEA,DEA-2025-0555,8FA MDMB-4en-PINACA,Supporting & Related Material,,2025-10-03T04:00:00Z,2025,10,,,2025-10-03T22:46:34Z,,0,0,09000064b8ff1b92
DEA-2025-0555-0004,DEA,DEA-2025-0555,SIGNED - OASH to DEA Ltr 8FA MDMB-PINACA.VAS,Supporting & Related Material,,2025-10-03T04:00:00Z,2025,10,,,2025-10-03T22:46:38Z,,0,0,09000064b8ff1b94
DEA-2025-0555-0002,DEA,DEA-2025-0555,MDMB-4en-PINACA 8F Oct 2025,Supporting & Related Material,,2025-10-02T04:00:00Z,2025,10,,,2025-10-03T01:16:43Z,,0,0,09000064b8fefe68
DEA-2025-0558-0001,DEA,DEA-2025-0558,Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction,Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:30:04Z,2025-19292,0,0,09000064b8ff064c
DEA-2025-0555-0001,DEA,DEA-2025-0555,Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I,Proposed Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,2025-11-04T04:59:59Z,2025-11-04T10:00:11Z,2025-19348,0,0,09000064b8ff06ce
DEA-2023-0016-0010,DEA,DEA-2023-0016,Controlled Substances Ordering System Modernization,Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:31:47Z,2025-19325,0,0,09000064b8ff074c
DEA-2025-0556-0001,DEA,DEA-2025-0556,"Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical",Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:20:48Z,2025-19349,0,0,09000064b8ff07c5
DEA-2025-0557-0001,DEA,DEA-2025-0557,Designation of P2P Methyl Glycidic Acid as a List I Chemical,Proposed Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,2025-11-04T04:59:59Z,2025-11-04T10:00:11Z,2025-19384,0,0,09000064b8ff05d4
DEA-2025-0522-0001,DEA,DEA-2025-0522,Bulk Manufacturer-Cargill Incorp(2025-19317)DEA1598,Notice,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,2025-12-02T04:59:59Z,2025-10-02T22:46:29Z,2025-19317,0,0,09000064b8fef93e
DEA-2025-0489-0001,DEA,DEA-2025-0489,Importer of Controlled-Groff NA Hemplex(2025-18901)DEA1603,Notice,,2025-09-30T04:00:00Z,2025,9,2025-09-30T04:00:00Z,2025-10-31T03:59:59Z,2025-09-30T16:13:02Z,2025-18901,0,0,09000064b8fe6490
DEA-2025-0456-0001,DEA,DEA-2025-0456,Bulk Manufacturer-Groff Health (2025-18244)DEA1600,Notice,,2025-09-22T04:00:00Z,2025,9,2025-09-22T04:00:00Z,2025-11-22T04:59:59Z,2025-11-20T10:00:15Z,2025-18244,0,0,09000064b8fd1b53
DEA-2024-0120-1884,DEA,DEA-2024-0120,Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h),Notice,,2025-09-19T04:00:00Z,2025,9,2025-09-19T04:00:00Z,,2025-09-19T20:15:52Z,,0,0,09000064b8fbef33
DEA-2024-0148-0006,DEA,DEA-2024-0148,Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I,Rule,,2025-09-18T04:00:00Z,2025,9,2025-09-18T04:00:00Z,,2025-10-03T01:28:48Z,2025-18103,0,0,09000064b8fb0ed1
DEA-2025-0423-0001,DEA,DEA-2025-0423,Importer of Controlled-Catalent Greenville Inc(2025-17819)DEA1597,Notice,,2025-09-16T04:00:00Z,2025,9,2025-09-16T04:00:00Z,2025-10-17T03:59:59Z,2025-09-16T16:07:31Z,2025-17819,0,0,09000064b8f936b1
DEA-2025-0393-0001,DEA,DEA-2025-0393,Importer of Controlled-Fresenius Kabi USA(2025-17583)DEA1594,Notice,,2025-09-12T04:00:00Z,2025,9,2025-09-12T04:00:00Z,2025-10-15T03:59:59Z,2025-09-12T16:30:55Z,2025-17583,0,0,09000064b8f712f8
DEA-2025-0392-0001,DEA,DEA-2025-0392,Bulk Manufacturer-Cambridge Isotope Lab(2025-17582)DEA1590,Notice,,2025-09-12T04:00:00Z,2025,9,2025-09-12T04:00:00Z,2025-11-13T04:59:59Z,2025-11-13T10:00:13Z,2025-17582,0,0,09000064b8f70247
DEA-2025-0394-0001,DEA,DEA-2025-0394,Importer of Controlled-Fisher Clinical Services(2025-17650)DEA1595,Notice,,2025-09-12T04:00:00Z,2025,9,2025-09-12T04:00:00Z,2025-10-15T03:59:59Z,2025-09-12T16:35:39Z,2025-17650,0,0,09000064b8f712fc
DEA-2025-0391-0001,DEA,DEA-2025-0391,Importer of Controlled Substances-Catalent Pharma(2025-17581)DEA1592,Notice,,2025-09-12T04:00:00Z,2025,9,2025-09-12T04:00:00Z,2025-10-15T03:59:59Z,2025-09-12T16:19:47Z,2025-17581,0,0,09000064b8f70246
DEA-2025-0390-0001,DEA,DEA-2025-0390,Importer of Controlled-Cambridge Isotope Labs(2025-17580)DEA1591,Notice,,2025-09-12T04:00:00Z,2025,9,2025-09-12T04:00:00Z,2025-10-15T03:59:59Z,2025-09-12T16:10:30Z,2025-17580,0,0,09000064b8f730a1
DEA-2025-0357-0001,DEA,DEA-2025-0357,Importer of Controlled-Biopharmaceutical Research(2025-17503)DEA1580,Notice,,2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,2025-10-15T03:59:59Z,2025-09-11T17:29:27Z,2025-17503,0,0,09000064b8f6be50
DEA-2025-0324-0001,DEA,DEA-2025-0324,Importer of Controlled-VA Cooperative Studies(2025-17210) DEA1561,Notice,,2025-09-08T04:00:00Z,2025,9,2025-09-08T04:00:00Z,2025-10-09T03:59:59Z,2025-10-09T09:00:21Z,2025-17210,0,0,09000064b8f52549
DEA-2025-0291-0001,DEA,DEA-2025-0291,Importer of Controlled-Cambrex High Point(2025-16002)DEA1583,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-09-23T03:59:59Z,2025-08-21T16:43:49Z,2025-16002,0,0,09000064b8f0b5ab
DEA-2025-0292-0001,DEA,DEA-2025-0292,Bulk Manufacturer-Cambrex High Point(2025-16003)DEA1585,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-10-21T03:59:59Z,2025-09-03T09:00:19Z,2025-16003,0,0,09000064b8f0b5b0
DEA-2025-0294-0001,DEA,DEA-2025-0294,Importer of Controlled Sub-Cambrex Charles City(2025-16005)DEA1587,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-09-23T03:59:59Z,2025-08-21T16:58:14Z,2025-16005,0,0,09000064b8f0b5bb
DEA-2025-0296-0001,DEA,DEA-2025-0296,Importer of Controlled-Vici Health Sciences(2025-16006)DEA1588,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-09-23T03:59:59Z,2025-08-21T17:07:24Z,2025-16006,0,0,09000064b8f0b5c9
DEA-2025-0293-0001,DEA,DEA-2025-0293,Importer of Controlled-Catalent CTS(2025-16004)DEA1586,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-09-23T03:59:59Z,2025-08-21T16:53:14Z,2025-16004,0,0,09000064b8f0b5b4
DEA-2025-0295-0001,DEA,DEA-2025-0295,Bulk Manufacturer-Continuus Pharma(2025-16007)DEA1589,Notice,,2025-08-21T04:00:00Z,2025,8,2025-08-21T04:00:00Z,2025-10-21T03:59:59Z,2025-08-21T17:02:58Z,2025-16007,0,0,09000064b8f0b5c1
DEA-2024-0118-0003,DEA,DEA-2024-0118,Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I,Rule,,2025-08-15T04:00:00Z,2025,8,2025-08-15T04:00:00Z,,2025-08-15T17:55:48Z,2025-15566,0,0,09000064b8f008ec
DEA-2025-0267-0001,DEA,DEA-2025-0267,Bulk Manufacturer-Benuvia Operations(2025-15279)DEA1584,Notice,,2025-08-12T04:00:00Z,2025,8,2025-08-12T04:00:00Z,2025-10-15T03:59:59Z,2025-08-12T16:23:23Z,2025-15279,0,0,09000064b8ef7540
DEA-2025-0266-0001,DEA,DEA-2025-0266,Importer of Controlled-Chattem Chemicals(2025-15159)DEA1577,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-09-11T09:00:21Z,2025-15159,0,0,09000064b8ef5ec3
DEA-2025-0265-0001,DEA,DEA-2025-0265,Importer of Controlled-Benuvia Operations(2025-15158)DEA1576,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-09-11T09:00:21Z,2025-15158,0,0,09000064b8ef5ec0
DEA-2025-0262-0001,DEA,DEA-2025-0262,Importer of Controlled-Curia New York(2025-15156)DEA1574,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-09-11T09:00:21Z,2025-15156,0,0,09000064b8ef5e2f
DEA-2025-0261-0001,DEA,DEA-2025-0261,Bulk Manufacturer-Chattam Chemicals(2025-15161)DEA1581,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-10-11T03:59:59Z,2025-08-11T17:13:34Z,2025-15161,0,0,09000064b8ef5e03
DEA-2025-0264-0001,DEA,DEA-2025-0264,Bulk Manufacturer-Cambrex Charles(2025-15157)DEA1575,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-10-11T03:59:59Z,2025-08-11T17:26:54Z,2025-15157,0,0,09000064b8ef5e8d
DEA-2025-0259-0001,DEA,DEA-2025-0259,Importer of Controlled-Galephar Pharma(2025-15155)DEA1573,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-08-11T17:04:37Z,2025-15155,0,0,09000064b8ef3bef
DEA-2025-0263-0001,DEA,DEA-2025-0263,Importer of Controlled-Experic LLC(2025-15160)DEA1579,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-08-11T17:22:16Z,2025-15160,0,0,09000064b8ef5e87
DEA-2025-0260-0001,DEA,DEA-2025-0260,Bulk Manufacturer-Biopharmaceutical(2025-15162)DEA1582,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-10-11T03:59:59Z,2025-08-11T17:09:15Z,2025-15162,0,0,09000064b8ef5dfd
DEA-2025-0258-0001,DEA,DEA-2025-0258,Importer of Controlled-Veterans Pharma(2025-15153)DEA1564,Notice,,2025-08-11T04:00:00Z,2025,8,2025-08-11T04:00:00Z,2025-09-11T03:59:59Z,2025-09-11T09:00:20Z,2025-15153,0,0,09000064b8ef3bed
DEA-2025-0192-0003,DEA,DEA-2025-0192,"Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance",Rule,,2025-08-08T04:00:00Z,2025,8,2025-08-08T04:00:00Z,,2025-09-10T04:16:28Z,2025-15177,0,0,09000064b8ef0c9b
DEA-2025-0225-0001,DEA,DEA-2025-0225,Bulk Manufacturer-ChemtosLLC(2025-15115)DEA1572,Notice,,2025-08-08T04:00:00Z,2025,8,2025-08-08T04:00:00Z,2025-10-08T03:59:59Z,2025-08-08T16:18:00Z,2025-15115,0,0,09000064b8ef2433
DEA-2025-0192-0001,DEA,DEA-2025-0192,2025-11462,Notice,,2025-08-01T04:00:00Z,2025,8,2025-08-01T04:00:00Z,,2025-08-02T00:45:56Z,,0,0,09000064b8ecca1d
DEA-2025-0192-0002,DEA,DEA-2025-0192,DEA-1494 Three Factor Analysis for Temporary Control of Seven Benzimidazole-Opioids,Supporting & Related Material,,2025-08-01T04:00:00Z,2025,8,,,2025-08-02T00:46:00Z,,0,0,09000064b8ecca29
DEA-2022-0145-0008,DEA,DEA-2022-0145,DEA989 HHS 8-Factor Analysis,Supporting & Related Material,,2025-07-25T04:00:00Z,2025,7,,,2025-07-25T21:33:08Z,,0,0,09000064b8ea2f07
DEA-2022-0145-0006,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I",Proposed Rule,,2025-07-25T04:00:00Z,2025,7,2025-07-25T04:00:00Z,2025-08-26T03:59:59Z,2025-08-21T09:01:13Z,2025-14022,0,0,09000064b8e9caad
DEA-2022-0145-0007,DEA,DEA-2022-0145,DEA989 DEA 8-Factor Analysis,Supporting & Related Material,,2025-07-25T04:00:00Z,2025,7,,,2025-07-25T21:33:05Z,,0,0,09000064b8e9d6f4
DEA-2022-0145-0005,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I",Rule,,2025-07-25T04:00:00Z,2025,7,2025-07-25T04:00:00Z,,2025-07-25T16:18:35Z,2025-14037,0,0,09000064b8e9cab5
DEA-2025-0161-0001,DEA,DEA-2025-0161,Importer of Controlled-AndersonBrecon(2025-13451)DEA1568,Notice,,2025-07-17T04:00:00Z,2025,7,2025-07-17T04:00:00Z,2025-08-19T03:59:59Z,2025-07-17T16:47:52Z,2025-13451,0,0,09000064b8e804b7